Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.37 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.37 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL678102 | 0.86 | SLC22A6 (0.45) | SMN1; SMN2SLC22A6FFAR3TDP1GPR84 | |
| SCHEMBL5077882 | 0.86 | SLC22A6 (0.45) | SMN1; SMN2SLC22A6FFAR3TDP1GPR84 | |
| SCHEMBL5960145 | 0.86 | SMN1; SMN2 (0.48) | SMN1; SMN2SLC22A6FFAR3TDP1CACNA2D1 | |
| SCHEMBL27753421 | 0.83 | SLC22A6 (0.43) | SMN1; SMN2SLC22A6FFAR3TDP1GPR84 | |
| SCHEMBL27945267 | 0.83 | SLC22A6 (0.43) | SMN1; SMN2SLC22A6FFAR3TDP1GPR84 | |
| SCHEMBL18222806 | 0.82 | MME (0.39) | SMN1; SMN2SLC22A6FFAR3TDP1CACNA2D1 | |
| SCHEMBL5078846 | 0.82 | SLC22A6 (0.43) | SMN1; SMN2SLC22A6FFAR3TDP1CACNA2D1 | |
| SCHEMBL10751531 | 0.80 | TDP1 (0.40) | SMN1; SMN2SLC22A6FFAR3TDP1CACNA2D1 | |
| SCHEMBL28599334 | 0.80 | SLC22A6 (0.36) | SMN1; SMN2SLC22A6FFAR3TDP1CACNA2D1 | |
| SCHEMBL5516785 | 0.80 | HDAC1 (0.42) | SMN1; SMN2SLC22A6FFAR3TDP1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109952360-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device | 东友精细化工有限公司 | 2022-03-22 | — | — | CN | claimed |
| EP-1747183-B1 | METHOD OF PREPARING ALKOXYLATION CATALYSTS AND THEIR USE IN ALKOXYLATION PROCESSES | HARCROS CHEMICALS INC (US) | 2018-06-06 | — | — | EP | claimed |
| EP-4641061-A1 | OIL-WELL METAL PIPE | NIPPON STEEL CORPORATION (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-4570255-A1 | SPORICIDAL ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | Silva, Renata Moisés Iwamizu (BR) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024135464-A1 | OIL-WELL METAL PIPE | 日本製鉄株式会社 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024031162-A1 | SPORICIDAL ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | DA SILVA, Tasso Pereira (BR) | 2024-02-15 | — | — | WO | disclosed |
| CN-112898128-B | Synthesis method of russula rupestris ant pheromone component 3-ethyl-4-methylpentanol | 苏州华道生物药业股份有限公司 | 2023-07-07 | — | — | CN | disclosed |
| US-20230212148-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-07-06 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-109952360-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device | 东友精细化工有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-112898128-A | Method for synthesizing 3-ethyl-4-methylpentanol as pheromone component of limonum aureum | 苏州华道生物药业股份有限公司 | 2021-06-04 | — | — | CN | disclosed |
| WO-2017027834-A1 | MANGANESE-BASED CHELATE CONJUGATES FOR MOLECULAR MR IMAGING | THE GENERAL HOSPITAL CORPORATION (US) | 2017-02-16 | — | — | WO | disclosed |
| US-8026277-B2 | Flavor composition or fragrance composition, product containing the flavor composition or fragrance composition, and novel ester compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-09-27 | — | — | US | disclosed |
| EP-2098586-B1 | FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, PRODUCT CONTAINING THE FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, AND NOVEL ESTER COMPOUND | TAKASAGO PERFUMERY CO LTD (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20100081725-A1 | FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, PRODUCT CONTAINING THE FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, AND NOVEL ESTER COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-2098586-A1 | FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, PRODUCT CONTAINING THE FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, AND NOVEL ESTER COMPOUND | Takasago International Corporation (JP) | 2009-09-09 | — | — | EP | disclosed |
| US-3932285-A | MONOCARBOXYLIC ACID | TENNECO CHEMICALS, INC. (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081725-A1 | FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, PRODUCT CONTAINING THE FLAVOR COMPOSITION OR FRAGRANCE COMPOSITION, AND NOVEL ESTER COMPOUND | MEP1A, NOTUM, MEP1B | SMN1; SMN2 3363/4885SLC22A6 4428/4885FFAR3 306/4885 |
| US-20230212148-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | CPSF6, NFATC1, CPSF1 | SMN1; SMN2 3976/4885SLC22A6 449/4885FFAR3 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.